Effect of sildenafil added to antifibrotic treatment in idiopathic pulmonary fibrosis

Abstract Sildenafil is a phosphodiesterase-5 inhibitor used to treat idiopathic pulmonary arterial hypertension; however, its benefits are unclear in patients with advanced idiopathic pulmonary fibrosis (IPF). We aimed to evaluate its effect as an add-on to antifibrotic agents on clinical outcomes o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jieun Kang, Jin Woo Song
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/98744e44e4c2472da78b957c76dcc9cc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!